Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 157

1.

Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.

Nelson JE, Brunt EM, Kowdley KV; Nonalcoholic Steatohepatitis Clinical Research Network.

Hepatology. 2012 Nov;56(5):1730-40. doi: 10.1002/hep.25856. Epub 2012 Sep 20.

PMID:
22611049
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.

Valenti L, Fracanzani AL, Bugianesi E, Dongiovanni P, Galmozzi E, Vanni E, Canavesi E, Lattuada E, Roviaro G, Marchesini G, Fargion S.

Gastroenterology. 2010 Mar;138(3):905-12. doi: 10.1053/j.gastro.2009.11.013. Epub 2009 Nov 18.

PMID:
19931264
[PubMed - indexed for MEDLINE]
3.

HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.

Chitturi S, Weltman M, Farrell GC, McDonald D, Kench J, Liddle C, Samarasinghe D, Lin R, Abeygunasekera S, George J.

Hepatology. 2002 Jul;36(1):142-9. Erratum in: Hepatology 2002 Nov;36(5):1307.

PMID:
12085358
[PubMed - indexed for MEDLINE]
4.

HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis.

Nelson JE, Bhattacharya R, Lindor KD, Chalasani N, Raaka S, Heathcote EJ, Miskovsky E, Shaffer E, Rulyak SJ, Kowdley KV.

Hepatology. 2007 Sep;46(3):723-9.

PMID:
17680648
[PubMed - indexed for MEDLINE]
5.

Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan.

Lin TJ, Lin CL, Wang CS, Liu SO, Liao LY.

World J Gastroenterol. 2005 Jul 7;11(25):3905-8.

PMID:
15991291
[PubMed - indexed for MEDLINE]
Free Article
6.

An epidemiologic study on the incidence and significance of HFE mutations in a Korean cohort with nonalcoholic fatty liver disease.

Lee SH, Jeong SH, Lee D, Lee JH, Hwang SH, Cho YA, Park YS, Hwang JH, Kim JW, Kim N, Lee DH, Kang W.

J Clin Gastroenterol. 2010 Aug;44(7):e154-61. doi: 10.1097/MCG.0b013e3181d347d9.

PMID:
20216079
[PubMed - indexed for MEDLINE]
7.

Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.

Valenti L, Swinkels DW, Burdick L, Dongiovanni P, Tjalsma H, Motta BM, Bertelli C, Fatta E, Bignamini D, Rametta R, Fargion S, Fracanzani AL.

Nutr Metab Cardiovasc Dis. 2011 Aug;21(8):568-75. doi: 10.1016/j.numecd.2010.01.003. Epub 2010 Apr 13.

PMID:
20392616
[PubMed - indexed for MEDLINE]
8.

Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.

Bonkovsky HL, Jawaid Q, Tortorelli K, LeClair P, Cobb J, Lambrecht RW, Banner BF.

J Hepatol. 1999 Sep;31(3):421-9.

PMID:
10488699
[PubMed - indexed for MEDLINE]
9.

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.

Bugianesi E, Manzini P, D'Antico S, Vanni E, Longo F, Leone N, Massarenti P, Piga A, Marchesini G, Rizzetto M.

Hepatology. 2004 Jan;39(1):179-87.

PMID:
14752836
[PubMed - indexed for MEDLINE]
10.

Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.

Sangwaiya A, Manglam V, Busbridge M, Thursz M, Arnold J.

Eur J Gastroenterol Hepatol. 2011 Aug;23(8):721-4. doi: 10.1097/MEG.0b013e3283484716.

PMID:
21654321
[PubMed - indexed for MEDLINE]
11.

A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis.

Girelli D, Trombini P, Busti F, Campostrini N, Sandri M, Pelucchi S, Westerman M, Ganz T, Nemeth E, Piperno A, Camaschella C.

Haematologica. 2011 Apr;96(4):500-6. doi: 10.3324/haematol.2010.033449. Epub 2010 Dec 20.

PMID:
21173098
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.

Cheng R, Barton JC, Morrison ED, Phatak PD, Krawitt EL, Gordon SC, Kowdley KV.

J Clin Gastroenterol. 2009 Jul;43(6):569-73. doi: 10.1097/MCG.0b013e3181919a33.

PMID:
19359997
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.

Raszeja-Wyszomirska J, Kurzawski G, Lawniczak M, Miezynska-Kurtycz J, Lubinski J.

World J Gastroenterol. 2010 May 28;16(20):2531-6.

PMID:
20503453
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease.

Valenti L, Rametta R, Dongiovanni P, Motta BM, Canavesi E, Pelusi S, Pulixi EA, Fracanzani AL, Fargion S.

PLoS One. 2012;7(11):e48804. doi: 10.1371/journal.pone.0048804. Epub 2012 Nov 5.

PMID:
23144979
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis.

Deguti MM, Sipahi AM, Gayotto LC, Palácios SA, Bittencourt PL, Goldberg AC, Laudanna AA, Carrilho FJ, Cançado EL.

Braz J Med Biol Res. 2003 Jun;36(6):739-45. Epub 2003 Jun 3.

PMID:
12792703
[PubMed - indexed for MEDLINE]
Free Article
16.

HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.

Valenti L, Girelli D, Valenti GF, Castagna A, Como G, Campostrini N, Rametta R, Dongiovanni P, Messa P, Fargion S.

Clin J Am Soc Nephrol. 2009 Aug;4(8):1331-7. doi: 10.2215/CJN.01370209. Epub 2009 Jun 18.

PMID:
19541813
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease.

Maliken BD, Nelson JE, Klintworth HM, Beauchamp M, Yeh MM, Kowdley KV.

Hepatology. 2013 May;57(5):1806-13. doi: 10.1002/hep.26238. Epub 2013 Mar 14.

PMID:
23325576
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.

Erhardt A, Maschner-Olberg A, Mellenthin C, Kappert G, Adams O, Donner A, Willers R, Niederau C, Häussinger D.

J Hepatol. 2003 Mar;38(3):335-42.

PMID:
12586300
[PubMed - indexed for MEDLINE]
19.

Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis.

Piperno A, Girelli D, Nemeth E, Trombini P, Bozzini C, Poggiali E, Phung Y, Ganz T, Camaschella C.

Blood. 2007 Dec 1;110(12):4096-100. Epub 2007 Aug 27.

PMID:
17724144
[PubMed - indexed for MEDLINE]
Free Article
20.

Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations.

Duseja A, Das R, Nanda M, Das A, Garewal G, Chawla Y.

World J Gastroenterol. 2005 Jan 21;11(3):393-5.

PMID:
15637751
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk